Optiray 300 New Zealand - English - Medsafe (Medicines Safety Authority)

optiray 300

obex medical ltd - ioversol 64% (provides 30% (300mg/ml) organically bound iodine) - solution for injection - 64 % - active: ioversol 64% (provides 30% (300mg/ml) organically bound iodine) excipient: sodium calcium edetate trometamol

OPTIRAY 300 (ULTRAJECT) SOLUTION Canada - English - Health Canada

optiray 300 (ultraject) solution

liebel-flarsheim company llc - ioversol - solution - 64% - ioversol 64% - roentgenography

Optiray 350 Prefilled Syringe 100ml Singapore - English - HSA (Health Sciences Authority)

optiray 350 prefilled syringe 100ml

transmedic pte ltd - ioversol - injection, solution - 741 mg/ml - ioversol 741 mg/ml

Optiray 350 Prefilled Syringe 125ml Singapore - English - HSA (Health Sciences Authority)

optiray 350 prefilled syringe 125ml

transmedic pte ltd - ioversol - injection, solution - 741 mg/ml - ioversol 741 mg/ml

Optiray 350 Prefilled Syringe 50ml Singapore - English - HSA (Health Sciences Authority)

optiray 350 prefilled syringe 50ml

transmedic pte ltd - ioversol - injection, solution - 741 mg/ml - ioversol 741 mg/ml

OPTIRAY 350 INJECTION 74% Singapore - English - HSA (Health Sciences Authority)

optiray 350 injection 74%

transmedic pte ltd - ioversol - injection - 741 mg/ml - ioversol 741 mg/ml

Optiray 240 mg I/ml solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

optiray 240 mg i/ml solution for injection or infusion

guerbet - ioversol - solution for injection/infusion - 240 mg i/ millilitre(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; ioversol

Optiray 320 mg I/ml solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

optiray 320 mg i/ml solution for injection or infusion

guerbet - ioversol - solution for injection/infusion - 320 mg i/ millilitre(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; ioversol

Optiray 350 mg I/ml solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

optiray 350 mg i/ml solution for injection or infusion

guerbet - ioversol - solution for injection/infusion - 350 mg i/ millilitre(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; ioversol

OPTIRAY 350- ioversol injection
OPTIRAY 320- ioversol injection
OPTIRAY 300- ioversol injection United States - English - NLM (National Library of Medicine)

optiray 350- ioversol injection optiray 320- ioversol injection optiray 300- ioversol injection

liebel-flarsheim company llc - ioversol (unii: n3rib7x24k) (ioversol - unii:n3rib7x24k) - ioversol 741 mg in 1 ml - optiray is indicated for: in adults - optiray 300: cerebral arteriography and peripheral arteriography. - optiray 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. - optiray 350: peripheral arteriography coronary arteriography, and left ventriculography. in pediatric patients - optiray 320 and optiray 350: angiocardiography. in adults - optiray 300: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 320: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 350: ct imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (iv-dsa). - in pediatric patients optiray 320: ct imaging of the head and body, and intravenous excretory urography. symptomatic hyperthyroidism risk summary postmarketing data with optiray use in pregnant women are insufficient to de